Mycoplasma Testing Market Report Examines Leading Companies And Growth Opportunities

The market for mycoplasma testing is poised for significant expansion in the coming years, driven by advancements in biopharmaceutical manufacturing and growing demands for contamination control. Let's explore the anticipated market growth, key players, emerging trends, and the major segments shaping the future of this rapidly evolving industry.

Projected Growth Trajectory of the Mycoplasma Testing Market
The mycoplasma testing market is expected to experience swift growth, reaching a valuation of $2.1 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 11.1%. Several factors contribute to this robust outlook, including the rapid growth of biopharmaceutical manufacturing, increased outsourcing in contract research organizations (CROs), heightened investment in genomic testing, stricter regulatory focus on contamination prevention, and the growing adoption of automated testing platforms. Notable trends forecasted in this period include the widespread use of PCR-based mycoplasma detection methods, a surge in rapid test kits for cell culture screening, rising demand for automated detection systems, greater utilization of assays and reagents in biopharma production, and expanded testing requirements in research and CRO environments.

The mycoplasma testing market size has grown rapidly in recent years. It will grow from $1.23 billion in 2025 to $1.38 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to high prevalence of mycoplasma contamination, increased reliance on cell culture testing, growth in diagnostic testing demand, early adoption of pcr methods, rising use of elisa techniques.

Download a free sample of the mycoplasma testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Prominent Companies Leading the Mycoplasma Testing Industry
Several influential players dominate the mycoplasma testing market landscape. This includes Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, and ScienCell Research Laboratories Inc.

Strategic Collaborations to Advance Testing Technologies
In May 2024, bioMérieux S.A., a biotechnology company based in France, announced a partnership with Belgian analytical service provider AnaBioTec. This collaboration aims to enhance mycoplasma testing methods by overcoming the drawbacks of traditional techniques, which often require lengthy processing times of up to 28 days and are not well-suited for the fast-paced biopharmaceutical sector. This alliance seeks to deliver faster and more efficient mycoplasma detection solutions tailored for modern industry demands.

View the full mycoplasma testing market report:
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovations in Digital PCR Kits Shaping Market Trends
Leading companies in the mycoplasma testing field are placing increased emphasis on launching digital PCR kits to strengthen their competitive positions. Digital PCR technology allows for highly precise quantification and analysis of nucleic acids such as DNA and RNA using a digital framework. For example, in November 2023, QIAGEN, headquartered in Germany, introduced three new QIAcuity digital PCR kits alongside updated software designed to broaden digital PCR applications in both biopharmaceutical research and food safety testing. These kits come in one, four, and eight-plate versions, with the one-plate variant capable of processing up to 384 samples within an eight-hour work shift. Among these, the QIAcuity Mycoplasma Quant Kit provides researchers with a reliable and accurate method to detect mycoplasma contamination throughout various research stages.

Breakdown of Key Market Segments Driving Growth in Mycoplasma Testing
This report organizes the mycoplasma testing market into several critical categories:
1) Product Types: Instruments, Assays, Kits, and Reagents
2) Technology Used: PCR, ELISA, Enzymatic Methods, DNA Staining, and Other Technologies
3) Applications: Cell Line Testing, Virus Testing, and End-of-Production Cell Testing
4) End Users: Pharmaceutical and Biotechnology Companies, Cell Banks and Laboratories, Contract Research Organizations, and Academic Research Institutes

Further subcategories include:
- Instruments such as Mycoplasma Detection Systems, Automated Test Equipment, and PCR Equipment
- Assays including Mycoplasma Assays, Qualitative Assays, and Quantitative Assays
- Kits encompassing Mycoplasma Detection Kits, Testing Kits for Cell Cultures, and Sample Preparation Kits
- Reagents consisting of Nucleic Acid Reagents, Cell Culture Reagents, and Staining Reagents

These diverse segments collectively contribute to the dynamic development and increasing demand within the mycoplasma testing market.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.